(63) demonstrated that melanoma cell-derived EVs could deliver miR-155 to fibroblasts NIH/3T3 and then elevated the expression of proangiogenic factors, including VEGFa, FGF2, and MMP9, by directly targeting SOCS1, thus triggering the proangiogenic switch of CAFs. The gene discussed is VEGFA; the disease is melanoma.